A B S T R A C T To test
INTRODUCTION
Bovine thyroid-stimulating hormone (bTSH) 1 has recently been shown to consist of two different subunits designated TSHa and TSH#. The subunits are separated by gel filtration in ammonium bicarbonate solution after treatment with 1.0 M propionic acid (1) . Neither subunit is, by itself, a thyroid stimulator. Similar subunits have also been isolated from luteinizing hormone (LH) (2, 3) . The a-chains of LH and TSH have identical or nearly identical amino acid sequences and they will substitute for one another in reconstituting biologically active LH or TSH with the al)propriate f-chain (1, 4, 5) .
Antisera to human or bovine TSH incubated in vitro with appropriate amounts of either bTSH or hTSH can produce a thyroid-stimulating material that in some studies has been found to be more active at 8 h than at 2 h in the McKenzie bioassay, thus resembling the long-acting thyroid stimulator (LATS) rather than TSH (6, 7). We thought it important to investigate further the possibility that LATS might represent an immune complex of either TSH-anti-TSH or a subunit of TSH with an appropriate antibody. Consequently, we prepared rabbit antisera to purified bTSH and its subunits (8) . In preliminary experiments, we found that sera from rabbits immunized with bTSH,8 contaminated with bTSH or with purified bTSH alone caused thyroid stimulation in the mouse. This biological activity of the undiluted serum disappeared after several weeks storage at -20°C. We then studied the 'Abbreviations used in this paper: a, alpha subunit; fi, beta subunit (after TSH or LH); b, bovine; BSA, bovine serum albumin; GARGG, goat anti-rabbit gamma globulin; h, human; LATS, long-acting thyroid stimulator; LH, luteinizing hormone; PBS, phosphate buffered saline; TSH, thyroid-stimulating hormone.
The Journal of Clinical Investigation Volume 52 December 1973* 2979-2985 2979 ability of these antisera to combine with and neutralize bTSH. Similar studies were also done with antisera to highly purified preparations of bTSH subunits. METHODS Animals. Healthy New Zealand white rabbits were immunized. Equal numbers of both sexes were used. Their weights at the beginning of the study ranged from 1.4 to 3.0 kg.
Hormone preparations. The preparations of bTSH used to make subunits had a potency of 30-40 U/mg. Two different groups of animals were immunized. The subunits of bTSH used for the first group (experiment I) contained significant thyroid-stimulating activity in both the McKenzie assay and by measurement of the uptake of 32P into chick thyroids. (The activity of the bTSHp subunit was 6%o of the original bTSH activity in the McKenzie assay, and the bTSHa was found to contain 10-15% of the original TSH activity in the chick assay.) Contamination of the subunit preparations with bTSH is the most probable cause of the residual activity. This results from incomplete separation of the subunits with subsequent recombination to form intact bTSH (5) . The subunits of LH were prepared by countercurrent distribution (1) . Their potency was approximately 0.04 X N.I.H.-LH-S1 standard for the a-subunit and 0.08 for the ,8-subunit.
In experiment II, highly purified subunits prepared by a second gel filtration were used for. immunization. These bTSH,8 and bTSHa subunits contained no detectable thyroid-stimulating activity when assayed at a concentration of 500 ng/mouse. They could be recombined to produce bTSH with approximately 25% of the original activity (5 Appropriate dilutions of rabbit sera were incubated 24 h with trace quantities of the polypeptides labeled with "I by the method of Greenwood, Hunter, and Glover (10).
Specific activities always exceeded 200 gGCi/tg. The labeled polypeptide was obtained as a single peak from Sephadex G-75 gel filtration. To separate globulin-bound from free hormone or subunit, goat anti-rabbit gammaglobulin (GAR-GG) was added in antibody excess (11, 12) . Control tubes without rabbit antisera were routinely included. Five concentrations of each antiserum were assayed. The resultant binding (percent of maximum) was plotted against amount of antiserum, and the amount needed for 50% binding was read from the curve.
These studies were performed with serum from the 52nd-day bleeding of six rabbits immunized with bTSH,3, four with bTSHa, four with bTSH, and one with LHfi in experiment I, and the 77th-day bleeding of six rabbits immunized with bTSHp, six with bTSHa, four with bTSH, and five with BSA in experiment II. Effects of antiscra onl the thyroid-stimulating activity of bTSH. Antisera were combined with bTSH in a rigidly prescribed manner so that final antiserum concentrations Effects of dilution of the TSH-anti-TSH complexes. In the experiments described in the previous paragraph, the antiserum-TSH mixtures were prepared and incubated in a 1.0 ml volume for subsequent dilution to 5.0 ml. Thus, ratios of antiserum and TSH were varied but the final dilution (from 1.0 ml to 5.0 ml) was constant. To assess the possible effect of dilution of the complexes in the mouse, complexes formed at a constant TSH to anti- 2980 Beall, Chopra, Solomon, Pierce (Fig. 2) .
The antisera from experiment II were less potent than the experiment I antisera in their ability to bind 100 a * ANTI-bTSH1G Mean±+SEM of each group is shown. Antisera to either bTSH or its subunits bind bTSH equally well. ['2'I]bTSH (Table I) . Although the mean binding of the anti-bTSH sera exceeded mean binding by antisubunit sera, the spread of values was large, and the differences were not significant. Antisera to LH and BSA did not bind ['I]bTSH. Neutralization of TSH by the antisera. Almost all of the antisera to bTSH and bTSHfi subunits were highly effective in neutralizing the biological activity of bovine TSH. 1 ml of the most potent-anti-bTSHiP serum (#29) was capable of neutralizing over 10,000 mU of bTSH (Table II) . The activity of individual antisera varied widely. The least active sera neutralized less than 25 mU bTSH/ml of antiserum. The nonneutralizing antibodies combine with bTSH but do not completely inhibit its biological activity. These soluble antigen-antibody complexes can be precipitated or neutralized by the addition of GARGG. Since we have been able to describe this activity only in terms of the bioassay results, quantitation of the antibody is difficult and not easily comparable with the binding activity.
There are several possibilities as to the nature of neutralizing and nonneutralizing antibodies. The most obvious possibility is that the neutralizing antibody combines with a hormonally active portion of bTSH while nonneutralizing antibody combines elsewhere. Neutralization could also be caused by precipitation or by high affinity antibodies that produce conformational changes in the TSH. The former seems unlikely since workers interested in radioimmunoassay of TSH have found that it is difficult to achieve complete precipitation. Another possibility is that the apparent differences in antibodies, neutralizing vs. nonneutralizing, More bTSH# is bound by anti-bTSHP than by anti-bTSH. These same antisera bind bTSH similarly. This difference supports the idea th-at the differing incidence of nonneutralizing antibodies in bTSH#-vs.
bTSH-immunized groups is due to the antigen used. The results of experiment II, using highly purified P-subunits, were similar in this respect to those of experiment I, using P-subunits contaminated with bTSH. In this context, the contamination seems insufficient to have affected the results. The increased binding and neutralizing activity of experiment I antisera as compared to experiment II antisera might be due to the subunit contamination with bTSH in experiment I, but a more likely explanation is that the purification procedure used in experiment II partly destroyed the antigenicity of the subunits.
Nonneutralizing antibodies to TSH form antigenantibody complexes in vitro that are biologically active thyroid stimulators in the mouse. The biological ac- 
